Stock A145720 DENTIUM CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Dentium CO., LTD

Equities

A145720

KR7145720009

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-28 pm EDT 		5-day change 1st Jan Change
131,600 KRW +1.31% Intraday chart for Dentium CO., LTD -1.35% +0.46%
2023 Dentium CO., LTD(KOSE:A145720) added to KOSPI 200 Index CI
2023 Dentium CO., LTD Reports Earnings Results for the First Quarter Ended March 31, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 463,965 354,442 601,948 862,389 1,129,730 1,134,904 - -
Enterprise Value (EV) 2 703 535.9 729.1 991.7 1,130 1,122 1,013 1,077
P/E ratio 23.9 x 15.8 x 10.8 x 10.1 x - 12.1 x 10.5 x 8.7 x
Yield 0.28% 0.49% 0.36% - - 0.27% 0.27% 0.32%
Capitalization / Revenue 1.84 x 1.54 x 2.06 x 2.42 x 2.87 x 2.49 x 2.17 x 1.86 x
EV / Revenue 2.79 x 2.33 x 2.5 x 2.79 x 2.87 x 2.46 x 1.94 x 1.77 x
EV / EBITDA 11.3 x 9.86 x 8.77 x 6.94 x - 6.34 x 5.01 x 4.58 x
EV / FCF -10.9 x 7.98 x 15.9 x -173 x - 11.7 x 7.94 x 8.02 x
FCF Yield -9.14% 12.5% 6.3% -0.58% - 8.51% 12.6% 12.5%
Price to Book 2.19 x 1.55 x 2.06 x 2.31 x - 2.44 x 1.99 x 1.49 x
Nbr of stocks (in thousands) 8,624 8,624 8,624 8,624 8,624 8,624 - -
Reference price 3 53,800 41,100 69,800 100,000 131,000 131,600 131,600 131,600
Announcement Date 2/27/20 2/23/21 3/22/22 2/28/23 2/28/24 - - -
1KRW in Million2KRW in Billions3KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 252.2 229.7 291.5 355.9 393.8 456 522.4 609.3
EBITDA 1 62.23 54.33 83.09 142.9 - 177 202.4 235.3
EBIT 1 47.92 39.6 69.88 124.4 131.9 156.6 181.8 215.7
Operating Margin 19% 17.23% 23.97% 34.95% 33.49% 34.34% 34.81% 35.39%
Earnings before Tax (EBT) 1 38.01 26.05 74.72 117.5 123.9 152.8 177.7 219
Net income 1 18.33 22.54 55.48 85.15 89.55 115.6 133.5 167
Net margin 7.27% 9.81% 19.03% 23.93% 22.74% 25.35% 25.55% 27.41%
EPS 2 2,250 2,595 6,434 9,873 - 10,854 12,544 15,125
Free Cash Flow 3 -64,236 67,140 45,932 -5,722 - 95,500 127,600 134,333
FCF margin -25,474.1% 29,223.07% 15,755.39% -1,608.01% - 20,942.98% 24,427.48% 22,045.95%
FCF Conversion (EBITDA) - 123,574.12% 55,280.69% - - 53,962.42% 63,035.69% 57,082.15%
FCF Conversion (Net income) - 297,807.54% 82,783.48% - - 82,621.39% 95,598.43% 80,439.12%
Dividend per Share 2 150.0 200.0 250.0 - - 354.3 354.3 426.7
Announcement Date 2/27/20 2/23/21 3/22/22 2/28/23 2/28/24 - - -
1KRW in Billions2KRW3KRW in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 71.17 94.07 74.53 96.67 90.66 94.02 68.81 106.4 93.78 124.8 86.93 118.9 112.4 137.8
EBITDA 1 - - - - 38.25 39.84 26.38 37.44 - - 28.9 47 41.3 54.8
EBIT 1 15.1 27.27 20.4 35.2 33.72 35.07 21.53 33.75 30.06 47.89 27.62 40.97 38.49 49.51
Operating Margin 21.22% 28.99% 27.37% 36.41% 37.2% 37.3% 31.29% 31.73% 32.05% 38.37% 31.77% 34.46% 34.23% 35.92%
Earnings before Tax (EBT) 1 18.44 27.04 21.84 40.99 37.44 17.26 23.71 30.47 30.01 41.04 28.05 42.5 42.9 51
Net income 1 14.06 18.53 15.68 36.14 24.53 8.794 18.32 21.17 24.07 27.02 20.55 30.57 29.17 35.27
Net margin 19.76% 19.7% 21.04% 37.39% 27.06% 9.35% 26.62% 19.9% 25.66% 21.65% 23.64% 25.71% 25.94% 25.58%
EPS - - - - - - - - - - - - - -
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 11/4/21 3/22/22 5/9/22 8/8/22 11/8/22 2/28/23 5/9/23 8/8/23 11/8/23 2/28/24 - - - -
1KRW in Billions
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 239 181 127 129 - - - -
Net Cash position 1 - - - - - 12.9 122 58
Leverage (Debt/EBITDA) 3.841 x 3.34 x 1.53 x 0.9048 x - - - -
Free Cash Flow 2 -64,236 67,140 45,932 -5,722 - 95,500 127,600 134,333
ROE (net income / shareholders' equity) 9.03% 10.3% 21.7% 25.7% - 22.4% 20.9% 20.8%
ROA (Net income/ Total Assets) 3.71% 4.26% 10.3% 13.8% - 13.9% 14.1% 14.7%
Assets 1 494.1 528.7 540.2 615.7 - 831.6 949.5 1,136
Book Value Per Share 3 24,522 26,588 33,841 43,354 - 53,850 66,079 88,554
Cash Flow per Share 3 -1,513 8,727 8,594 5,451 - 15,061 17,211 21,812
Capex 1 51.2 8.62 28.2 52.7 - 32.8 31.6 37.5
Capex / Sales 20.3% 3.75% 9.67% 14.82% - 7.18% 6.05% 6.15%
Announcement Date 2/27/20 2/23/21 3/22/22 2/28/23 2/28/24 - - -
1KRW in Billions2KRW in Million3KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Dentium CO., LTD

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
131,600 KRW
Average target price
171,625 KRW
Spread / Average Target
+30.41%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Devices & Implants

1st Jan change Capi.
DENTIUM CO., LTD Stock Dentium CO., LTD
+0.46% 814M
STRYKER CORPORATION Stock Stryker Corporation
+12.88% 128B
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-8.76% 10.65B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
+3.60% 8.82B
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
+19.18% 7.19B
GLAUKOS CORPORATION Stock Glaukos Corporation
+23.56% 4.99B
AXONICS, INC. Stock Axonics, Inc.
+7.46% 3.4B
ENOVIS CORPORATION Stock Enovis Corporation
-0.11% 3.03B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-4.80% 2.14B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-4.72% 2B
Medical Devices & Implants
  1. Stock Market
  2. Equities
  3. A145720 Stock
  4. Financials Dentium CO., LTD